BioSpace News Archive

Business

FARE Brings on Senior Vice President of External Affairs

Steve Danon to lead FARE’s advocacy, communications and marketing efforts

September 30, 2019
·
3 min read
Biotech Bay

New TAILORx Data, Published Today in JAMA Oncology, Add to Strong Evidence Base Reinforcing Unique Ability of Oncotype DX Breast Recurrence Score® Test to Guide Chemotherapy Treatment

Clinical Outcomes in Patients with High Recurrence Score® Results Presented Today in Oral Session at ESMO 2019 Congress

September 30, 2019
·
9 min read
Genetown

Ameresco Begins Phase Two of Energy Savings Project at the Medical University of South Carolina

Energy solutions company begins second phase of the comprehensive energy savings project

September 30, 2019
·
5 min read
FDA

Celltrion to Launch TemixysTM Double Combination Once-Daily Tablet for HIV Treatment in the U.S.

FDA Approved TemixysTM, a two-drug single-tablet antiretroviral (ARV) for HIV Treatment, will be Celltrion’s first branded product to be commercialized in 4Q 2019 through its direct-customer partnerships

September 30, 2019
·
4 min read
Business

Oracle Health Sciences and MMS Collaborate to Deliver Complex Database Build for Oncology Sponsor

MMS will share their learnings with peers at the Society for Clinical Data Management (SCDM) annual meeting in Baltimore, Md.

September 30, 2019
·
4 min read
Business

Apollo Medical Holdings Announces The Appointment Of Matthew Mazdyasni To Its Board Of Directors And Appointment Of New Interim Chief Technology Officer

Apollo Medical Holdings, Inc., an integrated population health management company, announced the appointment of Matthew Mazdyasni to its Board of Directors and Brandon Sim as its Interim Chief Technology Officer.

September 30, 2019
·
3 min read
Drug Development

Annexon Biosciences Reports Top-line Phase 1b Results for Novel C1q Inhibitor ANX005 in Guillain-Barré Syndrome

Annexon Biosciences announced encouraging results from a Phase 1b dose-ranging clinical trial to evaluate its anti-C1q antibody, ANX005.

September 30, 2019
·
4 min read
Business

SELF CARE CATALYSTS Appoints Nigel Page as Chief Executive Officer. Grace Castillo-Soyao, Founder and Executive Chair to Drive Innovation.

Self Care Catalysts Inc., a patient-driven Real World Evidence, Research, and Digital Therapeutics company is pleased to announce that Nigel Page joins the company as Chief Executive Officer.

September 30, 2019
·
2 min read
Business

SCIEX and Protein Metrics Join Forces to Meet Biopharmaceutical Customers’ AI and Automation-driven Data Requirements

Integration to empower fast data processing from all SCIEX high resolution accurate mass platforms as digital transformation of life sciences industry and push towards Precision Medicine continues to drive demand for data

September 30, 2019
·
3 min read
Drug Development

Deciphera Pharmaceuticals Announces Late-Breaking Oral Presentation at the ESMO 2019 Congress Demonstrating Positive Results from INVICTUS Pivotal Phase 3 Study of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors

INVICTUS pivotal Phase 3 clinical study of ripretinib in patients with advanced gastrointestinal stromal tumors (GIST) in an oral session at the European Society for Medical Oncology (ESMO) 2019 Congress.

September 30, 2019
·
10 min read